Post-warranty Preventive Maintenance and Repair Services on a liquid chromatography mass spectrometry (LC/MS) system
The U.S. Food and Drug Administration (FDA), specifically the Center for Biologics Evaluation and Research (CBER), is seeking post-warranty preventive maintenance and repair services for a liquid chromatography mass spectrometry (LC/MS) system. The requirement encompasses support for a Dionex Ultimate 3000 NCS-3500RS NANO UHPLC system interfaced with an ECLIPSE ORBITRAP ETD Mass Spectrometer, which the FDA uses to investigate glycoconjugate-based vaccine antigen structures. This pre-solicitation notice, issued for market research purposes, is intended to identify small business sources capable of providing these specialized services, though other vendors are also encouraged to submit capability statements. The FDA is particularly interested in vendors classified under NAICS Code 811210 (Electronic and Precision Equipment Repair and Maintenance) with a small business size standard of $34 million. Interested firms must submit a capability statement to Warren.Dutter@fda.hhs.gov demonstrating their ability to meet minimum requirements and providing information on the country of manufacture of products offered, with a response deadline of April 13, 2026.
No specific set-aside designation has been applied to this procurement. The pre-solicitation notice does not identify any current contractors or incumbents, nor does it provide an estimated award value or budget range for the eventual contract. While the notice emphasizes that this is market research to determine available sources rather than a formal request for proposal, the acquisition is driven by the FDA's need to maintain operational continuity, ensure accurate experimental results, and protect the government's investment in the LC/MS instrumentation. The specific equipment serial numbers are provided (Dionex SN: 8170238 and ECLIPSE ORBITRAP ETD SN: FSN40119), indicating the precise nature of the maintenance and repair services required. The compressed timeline, with responses due within six days of posting, suggests that the FDA anticipates moving relatively quickly toward formal solicitation once market research is complete.
FDA-SSN-133612 Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services
4/7/26, 5:24 PM Post-warranty Preventive Maintenance and Repair Services on a liquid chromatography mass spectrometry (LC/MS) system
The Food and Drug Administration Office of Acquisition and Grant Services seeks post-warranty preventive maintenance and repair services on a Dionex Ultimate 3000 NCS-3500RS NANO UHPLC system interfaced to an ECLIPSE ORBITRAP ETD Mass Spectrometer, with quotes due June 15, 2026 by 1:00 P.M. Central Time. This is a small business set-aside under NAICS 811210, Electronic and Precision Equipment Repair and Maintenance, with a $34 million small business size standard.
Place of performance is the FDA/CBER White Oak Campus in Silver Spring, Maryland. The contract consists of one base year (July 1, 2026 through June 30, 2027) plus two optional one-year periods, firm fixed pricing required for all line items. Services include one scheduled on-site preventive maintenance visit annually with parts, unlimited on-site corrective maintenance within three business days of call (after two business days of attempted remote resolution), unlimited technical support Monday through Friday 8:00 A.M. to 5:00 P.M. Eastern Time, access to OEM technical developments and updates, and OEM-certified replacement parts and labor. Shipping and handling must be included in pricing.
Evaluation criteria are technical capability, past performance within the last three years for the same or substantially similar services, and price, with technical capability and past performance collectively more important than price. Contractors must certify FAR 52.222-48 Service Contract Act compliance, submit Section 508 accessibility conformance reports for invoices and service records, provide detailed technical information demonstrating capability to meet all requirements, and include their Unique Entity ID with the quote. Payment terms are Net 30 days after government acceptance of invoices submitted electronically through the Department of Treasury Invoice Processing Platform. The Contracting Officer is Warren Dutter (301-796-2486, warren.dutter@fda.hhs.gov).
75F40126Q133612 Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services
6/8/26, 11:34 AM